| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia
|
Hovingh, G. Kees
|
|
2018
|
12 |
6 |
p. 1463-1470
|
article
|
| 2 |
Author Index to Volume 12
|
|
|
2018
|
12 |
6 |
p. e1-e6
|
article
|
| 3 |
Autosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting
|
Martín-Campos, Jesús M.
|
|
2018
|
12 |
6 |
p. 1452-1462
|
article
|
| 4 |
Biphasic dyslipidemia in a patient with painless thyroiditis
|
Murase, Toshio
|
|
2018
|
12 |
6 |
p. 1367-1370
|
article
|
| 5 |
Cardiovascular outcomes during extended follow-up of the AIM-HIGH trial cohort
|
Probstfield, Jeffrey L.
|
|
2018
|
12 |
6 |
p. 1413-1419
|
article
|
| 6 |
Circulating oleic acid levels are related to greater risks of cardiovascular events and all-cause mortality: The Multi-Ethnic Study of Atherosclerosis
|
Steffen, Brian T.
|
|
2018
|
12 |
6 |
p. 1404-1412
|
article
|
| 7 |
Coronary computed tomography angiogram in familial hypercholesterolemia: A double edge sword
|
Mirzaee, Sam
|
|
2018
|
12 |
6 |
p. 1549
|
article
|
| 8 |
Corrigendum to prevalence of cardiovascular risk factors among patients presenting with premature myocardial infarction in the Middle East [Journal of Clinical Lipidology 12/2 (2018) 523–525]
|
|
|
2018
|
12 |
6 |
p. 1552
|
article
|
| 9 |
Differences in heme and hemopexin content in lipoproteins from patients with sickle cell disease
|
Vendrame, Felipe
|
|
2018
|
12 |
6 |
p. 1532-1538
|
article
|
| 10 |
Differential effects of restrictive and malabsorptive bariatric surgery procedures on the serum lipidome in obese subjects
|
Ramos-Molina, Bruno
|
|
2018
|
12 |
6 |
p. 1502-1512
|
article
|
| 11 |
Editorial Board
|
|
|
2018
|
12 |
6 |
p. A1-A4
|
article
|
| 12 |
Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study
|
Oscarsson, Jan
|
|
2018
|
12 |
6 |
p. 1390-1403.e4
|
article
|
| 13 |
Extremely high levels of high-density lipoprotein cholesterol and increased risk of cardiovascular mortality
|
Kawada, Tomoyuki
|
|
2018
|
12 |
6 |
p. 1550-1551
|
article
|
| 14 |
Feasibility of a plasma bioassay to assess oxidative protection of low-density lipoproteins by high-density lipoproteins
|
Swertfeger, Debi K.
|
|
2018
|
12 |
6 |
p. 1539-1548
|
article
|
| 15 |
From the editor: Lessons from the East
|
Guyton, John R.
|
|
2018
|
12 |
6 |
p. 1331-1332
|
article
|
| 16 |
Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1
|
El Khoury, Petra
|
|
2018
|
12 |
6 |
p. 1374-1382
|
article
|
| 17 |
In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members
|
Zawacki, Amy W.
|
|
2018
|
12 |
6 |
p. 1445-1451
|
article
|
| 18 |
Integrating lipid screening with ideal cardiovascular health assessment in pediatric settings
|
Blackett, Piers
|
|
2018
|
12 |
6 |
p. 1346-1357
|
article
|
| 19 |
JCL roundtable—Lipoprotein(a): The emerging risk factor
|
Marcovina, Santica M.
|
|
2018
|
12 |
6 |
p. 1335-1345
|
article
|
| 20 |
Keyword Index to Volume 12
|
|
|
2018
|
12 |
6 |
p. e7-e12
|
article
|
| 21 |
Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal
|
Boffa, Michael B.
|
|
2018
|
12 |
6 |
p. 1358-1366
|
article
|
| 22 |
MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue
|
Capel, Emilie
|
|
2018
|
12 |
6 |
p. 1420-1435
|
article
|
| 23 |
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society
|
Ariza, María José
|
|
2018
|
12 |
6 |
p. 1482-1492.e3
|
article
|
| 24 |
News from the NLA
|
|
|
2018
|
12 |
6 |
p. 1333-1334
|
article
|
| 25 |
Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease
|
Tada, Hayato
|
|
2018
|
12 |
6 |
p. 1436-1444
|
article
|
| 26 |
Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients
|
Mitsnefes, Mark M.
|
|
2018
|
12 |
6 |
p. 1513-1522.e4
|
article
|
| 27 |
Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study
|
van Capelleveen, Julian C.
|
|
2018
|
12 |
6 |
p. 1493-1501.e11
|
article
|
| 28 |
Response to letter entitled “Coronary computed tomography angiogram in familial hypercholesterolemia: A double edge sword” by Dr. Sam Mirzaee and Dr. James D Cameron
|
Pérez de Isla, Leopoldo
|
|
2018
|
12 |
6 |
p. 1549-1550
|
article
|
| 29 |
Response to the letter entitled “Extremely high levels of high-density lipoprotein cholesterol and increased risk of cardiovascular mortality” by Dr Kawada
|
Hirata, Aya
|
|
2018
|
12 |
6 |
p. 1551
|
article
|
| 30 |
Retinal microvascular dysfunction in hypercholesterolemia
|
Nägele, Matthias P.
|
|
2018
|
12 |
6 |
p. 1523-1531.e2
|
article
|
| 31 |
Table of Contents
|
|
|
2018
|
12 |
6 |
p. A5-A7
|
article
|
| 32 |
The clinical importance of recognizing capecitabine-induced hypertriglyceridemia: A case report and review of the literature
|
Leung, Jenny
|
|
2018
|
12 |
6 |
p. 1371-1373
|
article
|
| 33 |
The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016
|
Aryan, Zahra
|
|
2018
|
12 |
6 |
p. 1471-1481.e4
|
article
|
| 34 |
The spectrum of type III hyperlipoproteinemia
|
Sniderman, Allan D.
|
|
2018
|
12 |
6 |
p. 1383-1389
|
article
|
Journal description